PI
BTAI icon

Pennant Investors’s BioXcel Therapeutics BTAI Stock Holding History

Pennant Investors’s Portfolio BTAI Stock Details BTAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,244
Closed -$107K – 23
2024
Q2 		$107K Hold
5,244
– – 0.03% 43
2024
Q1 		$237K Hold
5,244
– – 0.06% 37
2023
Q4 		$248K Buy
+5,244
New +$248K 0.05% 38